Search company, investor...


Founded Year



Unattributed VC - II | Alive

Total Raised


Last Raised

$60M | 18 yrs ago

About Affymax

Affymax is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. The companys product candidate, Hematide, is currently in Phase 3 trials for the treatment of anemia associated with chronic renal failure. Anemia is a serious condition in which blood is deficient in red blood cells and hemoglobin. It is common in patients with chronic renal failure, cancer, heart failure, inflammatory diseases and other critical illnesses, as well as in the elderly. If left untreated, anemia may lead to chronic fatigue or increase the risk of other diseases or death.

Headquarters Location

4001 Miranda Avenue/4015 Miranda Avenue

Palo Alto, California, 94304,

United States


Missing: Affymax's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Affymax's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Affymax

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Affymax is included in 1 Expert Collection, including Cancer.



1,179 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

Affymax Patents

Affymax has filed 16 patents.

patents chart

Application Date

Grant Date


Related Topics




Autoimmune diseases, Hematopathology, Hepatotoxins, Androgens and anabolic steroids, Ketones


Application Date


Grant Date



Related Topics

Autoimmune diseases, Hematopathology, Hepatotoxins, Androgens and anabolic steroids, Ketones



Latest Affymax News

PEGylated Drugs Market Growth Drivers, Demands, Business Opportunities, Size, Share Global Trends and Analysis by Top Leading Players-F. Hoffmann-La Roche, Takeda Pharmaceutical Company, Affymax

Jan 13, 2021

Search jobs 13-Jan-2021 PEGylated Drugs Market Growth Drivers, Demands, Business Opportunities, Size, Share Global Trends and Analysis by Top Leading Players-F. Hoffmann-La Roche, Takeda Pharmaceutical Company, Affymax Global PEGylated Drugs Market Size, Share, Growth, Industry Trends and Forecast 2027 research report added by Report DBMR, predicts the industry’s performance for the upcoming years to help stakeholders in making the right decisions that can potentially garner strong returns. Further, the document provides comprehensive analysis of the key industry trends as well as the opportunities that will ensure an upward growth trajectory in the coming years. It also focuses on developing strategies for challenges faced by the industry. Moreover, an exhaustive discussion of the latest updates including the impact of COVID-19 pandemic is furnished in the study. Data Bridge Market Research analyses the ‘Global PEGylated Drugs Market to reach at an estimated value of USD 8,358.17 million and grow at a CAGR of 5.48% in the above-mentioned forecast period. Increase in research and development spending drives the PEGylated drugs market. Download Free Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry @ PEGylated Drugs Market Scenario PEGylation is a type of process which is referred as covalent and non-covalent attachment of polyethylene glycol polymer chains to bioactive molecules. It is a very promising technique which helps in increasing the therapeutic efficacy of medicines in clinical settings. Numerous PEGylated drugs have been approved by the Food and Drug Administration (FDA), and many drugs are being tested in clinical settings. Rising growth in biologics sector to propel the PEGylated drugs is the vital factor escalating the market growth, also rise in the adoption of protein-based drugs over non-protein-based drugs, increasing protein’s stability in the drugs, increased prevalence rate of lifestyle diseases, rising occurrence of cancer, rising spending on the healthcare expenditures due to increased disposable income and rising number of hospitals and clinics all over the globe are the major factors among others driving the PEGylated drugs market. Moreover, increasing opportunities in emerging markets and rising top-selling biologics drugs going off–patent in the near future will further create new opportunities for PEGylated drugs market in the forecasted period of 2021-2028. However, rising adverse reactions associated with PEGylated drugs and drug recalls are the major factors among others which will obstruct the market growth, and will further challenge the growth of PEGylated drugs market in the forecast period mentioned above. Global PEGylated Drugs Market Report covers the manufacturer’s data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data. Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers. To Understand How Covid-19 Impact Is Covered In This Report, Get Free Covid-19 Sample @ The PEGylated Drugs Market report also focuses on some of the key growth prospects, including new product launches, M and A, R and D, joint ventures, collaborations, agreements, partnerships, and PEGylated Drugs market growth of the key players functioning in the market, both in terms of regional and global scale. Analysts forecast the Global PEGylated Drugs market to grow at the highest CAGR during the forecast period 2021-2027. List of the Top Key Players of PEGylated Drugs Market: Enzon Pharmaceuticals Get Complete Report  (Including Full TOC, List of Tables & Figures, Graphs, and Chart) @ PEGylated Drugs Market Report covers the manufacturers data, including shipment, price, revenue, gross profit, interview record, business distribution, etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data. Besides, the report also covers segment data, including type segment, industry segment, channel segment, etc. cover different segment market size, both volume and value. It also cover different industry’s clients information, which is very important for the manufacturers. Global PEGylated Drugs Industry 2021 Market Research Report is spread across 350 pages and provides exclusive vital statistics, data, information, PEGylated Drugs market trends and competitive landscape details in this niche sector. PEGylated Drugs Market Segmented by: By Molecule (Protein, FAB’ Fragment, Enzyme and Aptamer) By Type (Interferons, Colony Stimulating Factors, Monoclonal Antibodies (mAbs), Other Types) By Disease Indication (Gastrointestinal Disorders, Cancer, Multiple Sclerosis, Hepatitis, Other Disease Indications) By Application (Cancer, Autoimmune Disease, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorder, and Others) By Sales Channel (Hospital Pharmacy, Online Provider, Retail Pharmacy) North America dominates the PEGylated drugs market due to rising prevalence of cancer along with advancements in the field of cancer research and rising usage of advanced drug delivery systems with PEGylation technology in this region. Europe is the second largest region in terms of growth in PEGylated drugs market due to increasing efforts by the government to reduce chronic disease burden due to the rising occurrence of cancer in the region. Scope of PEGylated Drugs market Report This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The PEGylated Drugs market report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts. Market dynamics of PEGylated Drugs Market The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing. For More Information or Query or, Customization before Buying Visit @ PEGylated Drugs Market Scope and Market Size On the basis of molecule, the PEGylated drugs market is segmented into protein, FAB’ fragment, enzyme and aptamer. Based on type, the PEGylated drugs market is segmented into interferons, colony stimulating factors, monoclonal antibodies (mAbs) and other types. Based on disease indication, the PEGylated drugs market is segmented into gastrointestinal disorders, cancer, multiple sclerosis, hepatitis and other disease indications. Based on application, the PEGylated drugs market is segmented into cancer, autoimmune disease, hepatitis, multiple sclerosis, hemophilia, gastrointestinal disorder, and others. The PEGylated drugs market is also segmented on the basis of sales channel into hospital pharmacy, online provider and retail pharmacy. This Report lets you identify the opportunities in PEGylated Drugs Market by means of a region: North America (the United States, Canada and Mexico) Europe (Germany, UK, France, Italy, Russia and Turkey, etc.) Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam)) South America (Brazil etc.) Research Objectives Of PEGylated Drugs Market Report: To Analyze The PEGylated Drugs Consumption (Value and Volume), Product Type And Application, History Data From 2010 To 2021, And PEGylated Drugs market Forecast To 2027. To Understand The Structure Of PEGylated Drugs Market By Identifying Its Various Sub segments. Focuses On The Key PEGylated Drugs Manufacturers, To Define, Describe And Analyze The Sales Volume, Value, Market Share, Market Competition Landscape, SWOT Analysis And Development Plans In Next Few Years. To Analyze The PEGylated Drugs Market With Respect To Individual Growth Trends, Future Prospects, And Their Contribution To The Total Market. To Share Detailed Information About The Key Factors Influencing The Growth Of The Market (Growth Potential, Opportunities, Drivers, Industry-Specific Challenges And Risks). To Analyze Competitive Developments Such As Expansions, Agreements, New Product Launches, And Acquisitions In The Market. To Strategically Profile The Key Players And Comprehensively Analyze Their Growth Strategies. Access Full Report Directly @ Table of Contents Report Overview: It includes the objectives and scope of the study and gives highlights of key market segments and players covered. It also includes years considered for the research study. Executive Summary: It covers industry trends with high focus on market use cases and top market trends, market size by regions, and global market size. It also covers market share and growth rate by regions. Key Players: Here, the report concentrates on mergers and acquisitions, expansions, analysis of key players, establishment date of companies, and areas served, manufacturing base, and revenue of key players. Breakdown by Product and Application: This section provides details about market size by product and application. Regional Analysis: All of the regions and countries analyzed in the report are studied on the basis of market size by product and application, key players, and market forecast. Profiles of International Players: Here, players are evaluated on the basis of their gross margin, price, sales, revenue, business, products, and other company details. Market Dynamics: It includes supply chain analysis, analysis of regional marketing, challenges, opportunities, and drivers analyzed in the report. Key Findings of the Research Study Appendix: It includes details about research and methodology approach, research methodology, data sources, authors of the study, and a disclaimer. Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia. Our Other Reports:- About Data Bridge Market Research, Private Ltd Data Bridge Market Research  Pvt  Ltd  is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market. Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve. Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include

Affymax Frequently Asked Questions (FAQ)

  • When was Affymax founded?

    Affymax was founded in 2001.

  • Where is Affymax's headquarters?

    Affymax's headquarters is located at 4001 Miranda Avenue/4015 Miranda Avenue, Palo Alto.

  • What is Affymax's latest funding round?

    Affymax's latest funding round is Unattributed VC - II.

  • How much did Affymax raise?

    Affymax raised a total of $100M.

  • Who are the investors of Affymax?

    Investors of Affymax include Sprout Group, Apax Partners, MPM Capital, Bear Stearns, Merlin Biomed Group and 9 more.

  • Who are Affymax's competitors?

    Competitors of Affymax include Amgen.

Compare Affymax to Competitors

Sumitovant Logo

Sumitovant is a biopharmaceutical group focused on improving drug development. The company offers a tech-enabled approach to drug discovery, development and commercialization. It was founded in New York, New York.

DoubleRainbow Biosciences

DoubleRainbow Biosciences develops technologies rooted in the mechanistic understanding of specialized metabolic systems in plants and other organisms. The firm devises biosynthetic strategies that provide sustainable access to high-value natural products of medicinal or industrial significance.

Allergan Logo

Allergan is a global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. On June 25, 2019, Allergan was acquired by AbbVie at a valuation of $63000M.

Amgen Logo

Amgen (NASDAQ: AMGN) is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering human therapeutics. Amgen focuses on areas of high unmet medical need and leverages their biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. The company was founded in 1980 and is based in Thousand Oaks, California.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.